CBLL vs CV vs HTFL Stock Comparison

Ceribell, CapsoVision and Heartflow Prices as of Oct 26, 2026 Peers: Industry group
CBLL Ceribell, Inc.
$27.03 +14.1% 1M +109.7% 1Y
Market cap
$1.03B
P/E
–
Revenue (TTM)
$101.96M
Div. yield
–
Diagnostic Equipment Healthcare
2 wins
CV CapsoVision, Inc
$6.89 +3.6% 1M +40.6% 1Y
Market cap
$337.08M
P/E
–
Revenue (TTM)
$14.41M
Div. yield
–
Diagnostic Equipment Healthcare
HTFL Heartflow, Inc.
$57.01 +15.9% 1M +50.5% 1Y
Market cap
$5.15B
P/E
–
Revenue (TTM)
$202.91M
Div. yield
–
Diagnostic Equipment Healthcare
4 wins

Head to Head

6 decided of 12

Heartflow leads on 4 of the 12 questions below (Heartflow 4, Ceribell 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCBLLCVHTFLLeader
Larger companyMarket capitalisation $1.03B $337.08M $5.15B HTFL
Cheaper on earningsLower P/E, profitable companies only -15.6x -12.3x -51.4x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — — –
Faster revenue growthRevenue growth, trailing twelve months +31.7% +14.6% +42.5% HTFL
More profitableNet margin, trailing twelve months -64.7% -190.2% -49.4% HTFL
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA 1.6x — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +109.7% +40.6% +50.5% CBLL
Better 5-year returnAnnualised price return, 5 years — — — –
Less volatileAnnualised volatility, 1 year 52.2% 96.1% 76.9% CBLL
Higher overall scoreMean of the five percentile scores vs peers 38/100 36/100 57/100 HTFL

Percentile Scorecard

CBLLCVHTFL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCBLLCVHTFL
Valuation 21 #180 of 228 5 #217 of 228 8 #209 of 228
Growth 21 #175 of 221 42 #128 of 221 78 #50 of 221
Profitability 37 #132 of 208 23 #161 of 208 49 #107 of 208
Financial Health 81 #46 of 239 76 #59 of 239 91 #22 of 239
Shareholder Returns 29 #97 of 137 – –
Overall 38 36 57
  • CBLL ranked among 248 companies in Medical Devices and Diagnostics
  • CV ranked among 248 companies in Medical Devices and Diagnostics
  • HTFL ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCBLLCVHTFLSPY
1 month +14.1%+3.6%+15.9% -0.8%
3 months +49.1%+4.2%+124.7% +3.5%
6 months +27.9%+8.2%+79.7% +7.0%
Year to date +23.3%-35.5%+95.6% +12.2%
1 year +109.7%+40.6%+50.5% +13.0%

Risk

MeasureCBLLCVHTFLSPY
Volatility, 1Y 52.2%96.1%76.9% 12.7%
Downside volatility, 1Y 49.5%89.7%77.5% 12.7%
Beta vs S&P 500, 1Y 1.210.621.90 1.00
Return / volatility, 1Y 2.100.420.66 1.02
Max drawdown, 5Y -63.9%-67.8%-48.7% -25.4%
From 52-week high -2.3%-52.2%0.0% -1.8%
52-week high $27.68$14.42$57.01 $779.14
52-week low $10.92$4.59$20.49 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCBLLCVHTFL
P/E now vs peer median -15.6xmedian 30.6x -12.5xmedian 30.6x -49.2xmedian 30.6x
P/S now vs peer median 10.1xmedian 3.0x 23.9xmedian 3.0x 24.4xmedian 3.0x
EV/EBITDA now vs peer median -13.5xmedian 17.5x -12.5xmedian 17.5x —median 17.5x
P/FCF now vs peer median -18.9xmedian 23.3x —median 23.3x —median 23.3x
P/B now vs peer median 8.1xmedian 2.4x 26.2xmedian 2.4x 17.7xmedian 2.4x
PEG now vs peer median —median 0.87 —median 0.87 —median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCBLLCVHTFL
Revenue $101.96M $14.41M $202.91M
Gross profit $90.65M $7.55M $160.45M
Operating income -$69.97M -$27.71M -$64.46M
Net income -$66.00M -$27.42M -$100.19M
Free cash flow -$54.72M – –
R&D $22.95M $20.51M $77.26M
EPS (diluted) $-1.74 $-0.55 $-1.16
Cash & equivalents $32.66M – $34.36M
Total debt $19.98M – –
Shares (diluted) 38.03M 49.94M 86.40M
Enterprise value $432.08M $337.08M $4.90B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCBLLCVHTFL
P/E -15.6x -12.5x -49.2x
P/FCF -18.9x – –
P/Operating cash flow -19.1x – –
P/S 10.1x 23.9x 24.4x
P/B 8.1x 26.2x 17.7x
P/Tangible book 8.1x 26.2x 17.7x
EV/EBITDA -13.5x -12.5x –
EV/EBIT -13.2x -12.4x -72.9x
EV/Revenue 9.1x 23.9x 23.1x
EV/FCF -16.9x – –
EV/Operating cash flow -17.1x – –
PEG (3Y EPS CAGR) – – –

Growth

14 metrics
MetricCBLLCVHTFL
Revenue growth (1Y) 31.7% 14.6% 42.5%
Revenue CAGR (3Y) – – –
Gross profit growth (1Y) 33.4% 11.1% 48.8%
Gross profit CAGR (3Y) – – –
Operating income growth (1Y) -34.6% -36.1% -9.5%
Operating income CAGR (3Y) – – –
Net income growth (1Y) -33.6% -34.9% -18.3%
Net income CAGR (3Y) – – –
EPS growth (1Y) -27.5% 93.8% 91.4%
EPS CAGR (3Y) – – –
Operating cash flow growth (1Y) -44.3% – –
Operating cash flow CAGR (3Y) – – –
Free cash flow growth (1Y) -41.8% – –
Free cash flow CAGR (3Y) – – –

Profitability

14 metrics
MetricCBLLCVHTFL
Gross margin 88.9% 52.4% 79.1%
EBITDA margin -67.1% -190.7% –
Operating margin -68.6% -192.3% -31.8%
Pretax margin -64.7% -190.1% -49.4%
Net margin -64.7% -190.2% -49.4%
FCF margin -53.7% – –
Operating cash flow margin -53.0% – –
Return on equity -49.0% -207.5% -34.5%
Return on assets -38.3% -149.3% -28.5%
Return on invested capital – – –
Return on capital employed -45.1% -209.8% -20.9%
Asset turnover 0.6x 0.8x 0.6x
Cash conversion (OCF / net income) 0.8x – –
Stock comp / revenue 16.1% – 9.6%

Financial Health

11 metrics
MetricCBLLCVHTFL
Debt / assets 12.0% – –
Debt / equity 0.2x – –
Net debt / EBITDA 1.6x – –
Debt / FCF -0.4x – –
Liabilities / assets 22.9% 29.1% 18.8%
Equity / assets 77.1% 70.9% 81.2%
Interest coverage -38.6x – –
Current ratio 9.2x 3.4x 5.1x
Quick ratio 8.6x – 6.6x
Cash ratio 7.5x – 5.6x
Altman Z-score 14.35 22.08 41.82

Shareholder Returns

7 metrics
MetricCBLLCVHTFL
Dividend yield – – –
Net buyback yield -0.6% – –
Shareholder yield -0.6% 0.0% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCBLLCVHTFL
EPS, next fiscal year $-1.86FY2026 $-0.58FY2026 $-0.43FY2026
Revenue, next fiscal year $118.32MFY2026 $13.91MFY2026 $261.38MFY2026
Revenue growth, next FY +32.9%FY2026 +2.7%FY2026 +48.5%FY2026
Revenue growth, the year after +21.1% +46.0% +20.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCBLLCVHTFL
Held by institutions 79.9% 10.2% 100.0%
Institutions holding 124 50 192
Change in shares held, QoQ +2.2% +27.6% +133.0%
Institutions buying 74 36 140
Institutions selling 36 8 38
Buyers to sellers 2.06 4.50 3.68

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CBLLCVHTFL
CBLL 1.00 0.09 0.26
CV 0.09 1.00 0.04
HTFL 0.26 0.04 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CBLL, CV and HTFL?

Heartflow (HTFL) is the largest by market capitalisation: Ceribell (CBLL) $1.03B, CapsoVision (CV) $337.08M, Heartflow (HTFL) $5.15B.

Which company is growing faster?

Heartflow (HTFL) grew revenue fastest over the trailing twelve months: Ceribell (CBLL) +31.7%, CapsoVision (CV) +14.6%, Heartflow (HTFL) +42.5%.

Which company is more profitable?

Heartflow (HTFL) has the highest net margin (Ceribell (CBLL) -64.7%, CapsoVision (CV) -190.2%, Heartflow (HTFL) -49.4%).

Which stock has performed better?

Over the past year Ceribell (CBLL) returned the most: Ceribell (CBLL) +109.7%, CapsoVision (CV) +40.6%, Heartflow (HTFL) +50.5%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Ceribell (CBLL) has been the steadiest (Ceribell (CBLL) 52.2%, CapsoVision (CV) 96.1%, Heartflow (HTFL) 76.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CBLL, CV and HTFL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Heartflow (HTFL) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.